cro.directory
← Compare landing

Aliri Bioanalysis vs ChemPartner

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aliribio/chempartner

CategoryAliri BioanalysisChemPartner
Listed sitecrocro
SummaryBioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
Services
  • LC-MS Bioanalysis (Small Molecule)
  • Bioanalysis
  • Biomarker Assays
  • Pathology & Histology Services
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Discovery Research
  • Translational Research
  • Regulatory Affairs
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Target Identification & Validation
  • Clinical Imaging Core Lab
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • Protein Engineering
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Specialized & Large-Animal Models
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Pathology & Histology Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • Regulatory Affairs
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
Locations
  • Headquarters, Colorado Springs, Colorado, United States
  • Utah, Salt Lake City, Utah, United States
  • France, Loos, Hauts-de-France, France
  • Office, Salt Lake City, Utah, United States
  • Office, Loos, Nord, France
  • Salt Lake City, Salt Lake City, Utah, United States
  • Loos, Loos, Hauts-de-France, France
  • Boston Center of Excellence, Watertown, Massachusetts, USA
  • United Kingdom, Sandwich, Kent, United Kingdom
  • Europe, Copenhagen, Denmark, Denmark
  • Chengdu, Chengdu, China
  • Jiangsu, Jiangsu, China
  • Shanghai, Shanghai, China
  • Malaysia, Malaysia, Malaysia
  • Australia, Australia, Australia
  • Copenhagen, Copenhagen, Denmark
  • Malaysia, Malaysia
  • Jiangsu, Jiangsu, China
  • Australia, Australia
CertificationsData not yet provided.
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: cGMP Manufacturing / GMP Production
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.